A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
- PMID: 29439477
- PMCID: PMC5852445
- DOI: 10.3390/jcm7020029
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
Abstract
Millions of patients in the United States use anticoagulation for a variety of indications, such as the prevention of stroke in those with atrial fibrillation (AF) and the treatment and prevention of venous thrombosis. For over six decades warfarin was the only available oral anticoagulant, but now several DOACs are available and their use has become more prevalent in recent years. In spite of this increased use, many physicians remain reluctant to prescribe DOACs due to concerns about bleeding and reversibility.
Keywords: anticoagulants; reversal agents; serum levels.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Scott B.E., Curtain C.M., Chalmers L., Bereznicki L.R.E. Clinicians’ attitudes and perceptions regarding stroke prevention in atrial fibrillation. Res. Soc. Adm. Pharm. 2016;12:e22. doi: 10.1016/j.sapharm.2016.05.057. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
